Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Sell
1,704
-1
-0.1% -$215 0.12% 70
2026
Q1
$371K Sell
1,705
-10
-0.6% -$2.22K 0.11% 77
2025
Q4
$392K Hold
1,715
0.12% 70
2025
Q3
$397K Sell
1,715
-135
-7% -$27.5K 0.12% 71
2025
Q2
$343K Sell
1,850
-435
-19% -$80.8K 0.11% 80
2025
Q1
$479K Buy
2,285
+599
+36% +$116K 0.17% 63
2024
Q4
$300K Sell
1,686
-207
-11% -$38.1K 0.11% 82
2024
Q3
$374K Buy
1,893
+62
+3% +$11.6K 0.14% 77
2024
Q2
$314K Buy
1,831
+129
+8% +$21.4K 0.13% 80
2024
Q1
$310K Sell
1,702
-44
-3% -$7.58K 0.13% 80
2023
Q4
$271K Sell
1,746
-124
-7% -$18.1K 0.13% 85
2023
Q3
$279K Buy
1,870
+294
+19% +$43.2K 0.14% 83
2023
Q2
$212K Buy
1,576
+45
+3% +$6.6K 0.11% 94
2023
Q1
$244K Buy
+1,531
New +$234K 0.13% 86

Other funds holding ABBV

Joule Financial's ABBV Position: Q2 2026 in Review

Joule Financial reduced its AbbVie (ABBV) stake by 0.06% in Q2 2026, selling an estimated $215 and leaving 1,704 shares worth $429K. The position accounts for 0.12% of the portfolio, ranked #70.

Joule Financial first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $479K in Q1 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Joule Financial held 1,704 shares of AbbVie worth $429K as of Q2 2026.
  • Joule Financial sold 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.12% of Joule Financial's portfolio in Q2 2026, its #70 holding.
  • Joule Financial first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • Joule Financial's AbbVie position peaked at $479K in Q1 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Joule Financial's 13F filing for Q2 2026, filed 15 Jul 2026.